Tape-strips provide a minimally invasive approach to track therapeutic response to topical corticosteroids in atopic dermatitis patients

Caroline Meyer Olesen; Ana B. Pavel; Jianni Wu; Daniela Mikhaylov; Ester Del Duca; Yeriel Estrada; James G. Krueger; Ning Zhang; Maja Lisa Clausen; Tove Agner; Emma Guttman-Yassky

doi:10.1016/j.jaip.2020.08.037

Tape-strips provide a minimally invasive approach to track therapeutic response to topical corticosteroids in atopic dermatitis patients

Caroline Meyer Olesen, Ana B. Pavel, Jianni Wu, Daniela Mikhaylov, Ester Del Duca, Yeriel Estrada, James G. Krueger, Ning Zhang, Maja Lisa Clausen, Tove Agner^*, Emma Guttman-Yassky

^*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift › Letter › peer review

15 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Journal of Allergy and Clinical Immunology: In Practice
Vol/bind	9
Udgave nummer	1
Sider (fra-til)	576-579.e3
Antal sider	7
ISSN	2213-2198
DOI	https://doi.org/10.1016/j.jaip.2020.08.037
Status	Udgivet - jan. 2021

Bibliografisk note

Funding Information:
Conflicts of interest: J. G. Krueger is an employee of the Rockefeller University and has received research support (grants paid to his institution) and/or personal fees from Pfizer, Amgen, Janssen, Lilly, Merck, Novartis, Kadmon, Dermira, Boehringer, Innovaderm, Kyowa, BMS, Serono, BiogenIdec, Delenex, AbbVie, Sanofi, Baxter, Paraxel, Xenoport, and Kineta. T. Agner is an advisor/investigator or speaker for Pfizer Inc, AbbVie, Eli Lilly, LEO Pharma, Regeneron, and Sanofi-Genzyme. E. Guttman-Yassky is an employee of Mount Sinai and has received research funds (grants paid to the institution) from AbbVie, Celgene, Eli Lilly, Janssen, MedImmune/AstraZeneca, Novartis, Pfizer, Regeneron, Vitae, Glenmark, Galderma, Asana, Innovaderm, Dermira, and UCB and is also a consultant for Sanofi Aventis, Regeneron, Stiefel/GlaxoSmithKline, MedImmune, Celgene, Anacor, AnaptysBio, Dermira, Galderma, Glenmark, Novartis, Pfizer, Vitae, Leo Pharma, AbbVie, Eli Lilly, Kyowa, Mitsubishi Tanabe, Asana Biosciences, and Promius. The rest of the authors declare that they have no relevant conflicts of interest.

Adgang til dokumentet

10.1016/j.jaip.2020.08.037

Citationsformater

Olesen, C. M., Pavel, A. B., Wu, J., Mikhaylov, D., Del Duca, E., Estrada, Y., Krueger, J. G., Zhang, N., Clausen, M. L., Agner, T., & Guttman-Yassky, E. (2021). Tape-strips provide a minimally invasive approach to track therapeutic response to topical corticosteroids in atopic dermatitis patients. Journal of Allergy and Clinical Immunology: In Practice, 9(1), 576-579.e3. https://doi.org/10.1016/j.jaip.2020.08.037

Olesen, CM, Pavel, AB, Wu, J, Mikhaylov, D, Del Duca, E, Estrada, Y, Krueger, JG, Zhang, N, Clausen, ML, Agner, T & Guttman-Yassky, E 2021, 'Tape-strips provide a minimally invasive approach to track therapeutic response to topical corticosteroids in atopic dermatitis patients', Journal of Allergy and Clinical Immunology: In Practice, bind 9, nr. 1, s. 576-579.e3. https://doi.org/10.1016/j.jaip.2020.08.037

@article{fc0b8069beb94dbe8b6c6ebdaa941819,

title = "Tape-strips provide a minimally invasive approach to track therapeutic response to topical corticosteroids in atopic dermatitis patients",

author = "Olesen, {Caroline Meyer} and Pavel, {Ana B.} and Jianni Wu and Daniela Mikhaylov and {Del Duca}, Ester and Yeriel Estrada and Krueger, {James G.} and Ning Zhang and Clausen, {Maja Lisa} and Tove Agner and Emma Guttman-Yassky",

note = "Funding Information: Conflicts of interest: J. G. Krueger is an employee of the Rockefeller University and has received research support (grants paid to his institution) and/or personal fees from Pfizer, Amgen, Janssen, Lilly, Merck, Novartis, Kadmon, Dermira, Boehringer, Innovaderm, Kyowa, BMS, Serono, BiogenIdec, Delenex, AbbVie, Sanofi, Baxter, Paraxel, Xenoport, and Kineta. T. Agner is an advisor/investigator or speaker for Pfizer Inc, AbbVie, Eli Lilly, LEO Pharma, Regeneron, and Sanofi-Genzyme. E. Guttman-Yassky is an employee of Mount Sinai and has received research funds (grants paid to the institution) from AbbVie, Celgene, Eli Lilly, Janssen, MedImmune/AstraZeneca, Novartis, Pfizer, Regeneron, Vitae, Glenmark, Galderma, Asana, Innovaderm, Dermira, and UCB and is also a consultant for Sanofi Aventis, Regeneron, Stiefel/GlaxoSmithKline, MedImmune, Celgene, Anacor, AnaptysBio, Dermira, Galderma, Glenmark, Novartis, Pfizer, Vitae, Leo Pharma, AbbVie, Eli Lilly, Kyowa, Mitsubishi Tanabe, Asana Biosciences, and Promius. The rest of the authors declare that they have no relevant conflicts of interest.",

year = "2021",

month = jan,

doi = "10.1016/j.jaip.2020.08.037",

language = "English",

volume = "9",

pages = "576--579.e3",

journal = "Journal of Allergy and Clinical Immunology: In Practice",

issn = "2213-2198",

publisher = "Elsevier",

number = "1",

}

TY - JOUR

T1 - Tape-strips provide a minimally invasive approach to track therapeutic response to topical corticosteroids in atopic dermatitis patients

AU - Olesen, Caroline Meyer

AU - Pavel, Ana B.

AU - Wu, Jianni

AU - Mikhaylov, Daniela

AU - Del Duca, Ester

AU - Estrada, Yeriel

AU - Krueger, James G.

AU - Zhang, Ning

AU - Clausen, Maja Lisa

AU - Agner, Tove

AU - Guttman-Yassky, Emma

N1 - Funding Information: Conflicts of interest: J. G. Krueger is an employee of the Rockefeller University and has received research support (grants paid to his institution) and/or personal fees from Pfizer, Amgen, Janssen, Lilly, Merck, Novartis, Kadmon, Dermira, Boehringer, Innovaderm, Kyowa, BMS, Serono, BiogenIdec, Delenex, AbbVie, Sanofi, Baxter, Paraxel, Xenoport, and Kineta. T. Agner is an advisor/investigator or speaker for Pfizer Inc, AbbVie, Eli Lilly, LEO Pharma, Regeneron, and Sanofi-Genzyme. E. Guttman-Yassky is an employee of Mount Sinai and has received research funds (grants paid to the institution) from AbbVie, Celgene, Eli Lilly, Janssen, MedImmune/AstraZeneca, Novartis, Pfizer, Regeneron, Vitae, Glenmark, Galderma, Asana, Innovaderm, Dermira, and UCB and is also a consultant for Sanofi Aventis, Regeneron, Stiefel/GlaxoSmithKline, MedImmune, Celgene, Anacor, AnaptysBio, Dermira, Galderma, Glenmark, Novartis, Pfizer, Vitae, Leo Pharma, AbbVie, Eli Lilly, Kyowa, Mitsubishi Tanabe, Asana Biosciences, and Promius. The rest of the authors declare that they have no relevant conflicts of interest.

PY - 2021/1

Y1 - 2021/1

U2 - 10.1016/j.jaip.2020.08.037

DO - 10.1016/j.jaip.2020.08.037

M3 - Letter

C2 - 32889222

AN - SCOPUS:85090848649

SN - 2213-2198

VL - 9

SP - 576-579.e3

JO - Journal of Allergy and Clinical Immunology: In Practice

JF - Journal of Allergy and Clinical Immunology: In Practice

IS - 1

ER -